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There are different strategies to reduce BLV prevalence.
Eradication by culling of infected animals is not eco-
nomically sustainable in highly infected regions such as
Argentina, US or Japan. Segregation of BLV-infected
cows is expensive due to duplication of facilities. Finally,
several candidate vaccines based on recombinant viral
proteins were unsuccessful to protect from challenge.
Facing these problems, we propose a novel strategy
based on the use of a live-attenuated BLV provirus. The
rationale behind this strategy relies on the deletion of
genes required to induce pathogenesis leaving those
involved in infectivity, resulting in an attenuated mutant
with impaired transmissibility.
In a first set of experiments, we showed that the
mutant is infectious and elicits an efficient immune
response in sheep (n=3) and in cows (n=9). Lack of
spread to uninfected sentinels further supports the
safety of the vaccine. Based on these promising results,
a validation program in herd (n=105) is ongoing to eval-
uate the capacity of the candidate vaccine to protect
from wild-type BLV infection. The following experi-
ments are carried out: quantification of the proviral
loads, assessment of immune response efficiency (anti-
body titers, CTL response and cytokine profiling), mea-
sure of viral expression in vivo (qRT-PCR) and ex vivo
(expression of Tax and p24gag) and determination of
provirus clonality during infection.
This data will be instrumental for understanding the
basic mechanisms undergoing during BLV infection and
for elaborating a novel vaccine.
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